Abstracts and posters

Original work on rare dermatologic disease, presented as a poster in the exhibit hall across the scientific day.

Submission deadline
August 31, 2026
Decisions sent
September 21, 2026
Presented
Saturday, November 14

Guidelines

What is accepted
Original clinical research, case series, and health services research on rare dermatologic disease. Single case reports are accepted where the presentation or the management is genuinely instructive.
Formatting
Structured abstract of no more than 2,500 characters, under the headings Background, Methods, Results and Conclusions. Case series may substitute Cases for Methods. No figures or tables in the submitted text.
Authorship
List every author in presentation order with their institution. The presenting author must be registered for the meeting before the poster is scheduled.
Review
Each abstract is reviewed by two members of the scientific planning committee, blinded to author and institution. Decisions are sent on September 21.
Presentation
Accepted abstracts are presented as posters in the exhibit hall on Saturday November 14, with a staffed viewing period during the lunch break.
Conflict of interest
Every submission carries a conflict of interest disclosure for all authors. Disclosures are printed on the poster.

Submit an abstract

Everything below is saved only when you submit. There is no draft state, so write the abstract elsewhere and paste it in.

In presentation order, separated by semicolons. Mark the presenting author with an asterisk.

Structured under Background, Methods, Results and Conclusions. Case series may substitute Cases for Methods.

2,500 of 2,500 characters remaining

For every author. Write None if there is nothing to declare. Disclosures are printed on the poster.

Submissions close August 31, 2026. Decisions are sent September 21, 2026.